Concepedia

Xiaoming Xu

XX

Statistics

Publications

28

Citations

997

H-Index

18

Active since

2010

Affiliations

Second Affiliated Hospital of Zhejiang University(Current)

Zhejiang University

Jilin University

Jingzhou Central Hospital

Yangtze University

Xiaoming Xu is an author at Second Affiliated Hospital of Zhejiang University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2010–2024

28

Publications

28

Dimethyl fumarate induces necroptosis in colon cancer cells through <scp>GSH</scp> depletion/<scp>ROS</scp> increase/<scp>MAPKs</scp> activation pathway

Xin Xie, Yu Zhao, Chunyan Ma et al. · British Journal of Pharmacology · 2015 · 146 citations · Full text

, , +17

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies

Changchun Deng, Mark Lipstein, Luigi Scotto et al. · Blood · 2016 · 105 citations · Full text

, , +14

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway

Rui Xin, Huafeng Pan, Siliang Shao et al. · BMC Complementary and Alternative Medicine · 2017 · 99 citations · Full text

, , +14

Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma

Qiong Wu, Yafang Liu, Yue Ren et al. · European Journal of Cancer Prevention · 2010 · 59 citations

, , +13

Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway

Xiaoming Xu, Wei Mao, Qian Chen et al. · PLoS ONE · 2014 · 55 citations · Full text

, , +13

1–5 of 28